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ABSTRACT 
In the present work, the phenolic compounds of Castanea sativa, Filipendula ulmaria 
and Rosa micrantha flowers from Northeastern Portugal were characterized by HPLC-
DAD-ESI/MS. Furthermore, it was performed a screening of their antifungal potential 
against Candida species (C. albicans, C. glabrata, C. parapsilosis and C. tropicalis).  
C. sativa sample gave the highest amount of phenolic compounds (18973 ± 40 µg/g, fw) 
and hydrolysable tannins (14873 ± 110 µg/g). The highest amounts of phenolic acids 
(569 ± 20 µg/g) and flavonoids (6090 ± 253 µg/g) were obtained in F. ulmaria and R. 
micrantha samples, respectively. Hydrolysable tannins (e.g. tri and digalloyl HHDP 
glucose) were the main group of phenolic compounds in C. sativa and F. ulmaria 
samples, while flavonoids (e.g. (+)-catechin and procyanidin dimers and trimers) were 
the most abundant group in R. micrantha. Thus, the stronger effect showed by this latter 
against all the Candida species (MIC ≤ 0.155 mg/mL) and, particularly its fungicide 
effects in C. glabrata, might be related to the mentioned flavonoids that were 
inexistence in the other samples. 
 
Keywords: Medicinal flowers; Phenolic compounds; HPLC-DAD-ESI/MS; Candida 
species; Antifungal effect   
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1. Introduction 
In healthy individuals, many species of Candida are endogenous commensals of the 
gastrointestinal and urogenital tracts (Soll 2002). However, the prevalence of 
opportunistic fungal infections has been increasing dramatically over the recent decades 
and this is particularly evident in immunocompromised individuals, where these species 
become frequently opportunistic pathogens (Pfaller and Diekema 2007). Although, 
Candida albicans has been regarded as the most common causative agent of fungal 
infection in humans, nowadays other non-Candida albicans Candida (NCAC) species 
such as Candida glabrata, Candida tropicalis, and Candida parapsilosis, are emerging 
as significant nosocomial pathogens (Silva et al.,  2010). Moreover, NCAC species tend 
to be inherently less susceptible to the available antifungal drugs like the azole drugs 
and their derivatives, which continue to dominate as the antifungal agents of choice 
against Candida-related infections (Redding et al., 2002; Hajj eh et al., 2004; Ruhnke, 
2006). Furthermore this difficulty highlights the necessity to develop new alternative 
antifungal agents, in order to increase the spectrum of activity against Candida species. 
In the recent years the interest in natural compounds has raised, specifically some 
phenolic compounds including phenolic acids and flavonoids have been reported to 
inhibit various pathogenic bacteria and fungi (Rauha et al., 2000; Erasto et al., 2004; 
Tepe et al., 2004). Previous work conducted by our research group has highlighted the 
importance of wild plants as sources of phenolic compounds, such as phenolic acids, 
flavonoids and anthocyanins (Barros et al., 2011a). Moreover, flowers from semi-wild 
and wild species such as Castanea sativa, Filipendula ulmaria and Rosa micrantha 
have been traditionally used for several folk medicinal applications. Decoctions of C. 
sativa flowers are used for colds, cough, diarrhea and cholesterol; infusions of F. 
ulmaria are used for pneumonia and flu, urinary tract infections, rheumatism and 
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headache; and rosewater and decoctions of R. micrantha are used for acne, skin 
condition and injuries and eye inflammations (Camejo-Rodrigues et al., 2003; Novais et 
al., 2004; Neves et al., 2009; Carvalho, 2010). Their antioxidant potential was already 
reported by us (Barros et al., 2010; Guimarães et al., 2010; Barros et al., 2011b). 
As far as we know there are no reports neither on anti-NCAC activity of the mentioned 
wild flowers, nor in phenolic composition of R. micrantha. The available studies in 
literature described phenolic composition in C. sativa leaves (Calliste et al., 2001) and 
heartwood (Sanz et al., 2010), but not in its flowers. The phenolic composition of F. 
ulmaria flowers was studied, but with plant material from other European countries, i.e 
not growing under Mediterranean particular climatic and soil conditions (Krasnov et al., 
2006; Shilova et al., 2006; Pemp et al., 2007; Fecka, 2009; Harbourne et al., 2009; 
Krasnov et al., 2009). These flowers revealed the presence of a number of polyphenolic 
constituents including salicylates (e.g. spiraein, salicylic acid and methyl salicylate), 
flavonols (e.g. spiraeoside, hyperoside, rutin, kaempferol 4′-O-glucosides, quercetin-4′-
O-β-D-galactopyranoside and quercetin-3-O-β-glucopyranoside) and ellagitannins 
(tellimagrandins I and II, and rugosin D) (Krasnov et al., 2006; Shilova et al., 2006; 
Pemp et al., 2007; Fecka, 2009; Harbourne et al., 2009; Krasnov et al., 2009).  
It has been indicated that the antifungal activity of plant extracts is related to the 
different compounds present (with diverse functional groups and chemical substituents) 
and to possible synergistic interactions between them (Dorman and Deans, 2000). 
Therefore, in the present work, an exhaustive characterization of the phenolic 
compounds present in the extracts of Castanea sativa, Filipendula ulmaria and Rosa 
micrantha flowers was carried out by HPLC-DAD-ESI/MS. Furthermore, a screening 
of the antifungal potential of the those extracts against Candida species was also 
performed.  
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2. Materials and methods 
 
2.1. Samples 
Several ethnobotanical surveys conducted in Portugal for the last ten years (Camejo-
Rodrigues et al., 2003; Novais et al., 2004; Neves et al., 2009; Carvalho, 2010)  
highlighted the importance of folk medicine founded on traditional uses of plants. 
Considering our group previous research (Barros et al., 2010; Barros et al., 2011a; 
Barroset al., 2011b), several species were chosen to be screened for antifungal activity 
and further characterization, but only three of them highlight as interesting species: 
Castanea sativa Mill, Filipendula ulmaria (L.) Max and Rosa micrantha Borrer ex Sm. 
Flowers and inflorescences (the parts most cited for folk medicinal purposes by key-
informants) of the selected species were collected in the Natural Park of Montesinho 
territory (Trás-os-Montes, North-eastern Portugal), in 2009, according to local 
medicinal criteria of use and each plant growth pattern. Castanea sativa, the upright 
catkins during anthesis (flower fully opened and functional) in late summer; Filipendula 
ulmaria, the inflorescences with flowers fully open and functional in early summer; 
Rosa micrantha, the petals removed from floral buds and also from flowers after 
anthesis (anthers already opened, stamens becoming dry) in early spring. 
Voucher specimens are kept at the Herbário da Escola Superior Agrária de Bragança 
(BRESA). Each sample was lyophilized (Ly-8-FM-ULE, Snijders, Netherlands) and 
stored in the deep-freezer at -20ºC for subsequent analysis. 
 
2.2. Standards and reagents 
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HPLC-grade acetonitrile was obtained from Merck KgaA (Darmstadt, Germany). 
Formic and acetic acids were purchased from Prolabo (VWR International, France). The 
phenolic compounds standards were from Extrasynthese (Genay, France). RPMI 1640 
medium was purchased from Sigma (St Louis, MO, USA). All other chemicals were of 
analytical grade and purchased from chemical suppliers. Water was treated in a Milli-Q 
water purification system (TGI Pure Water Systems, USA). 
 
2.3. Preparation of the extracts 
Each sample (1 g) was extracted with 30 mL of methanol:water 80:20 (v/v) at room 
temperature, 150 rpm, for 1h. The extract was filtered through Whatman nº 4 paper. The 
residue was then re-extracted twice with additional 30 mL portions of methanol:water 
80:20 (v/v). The combined extracts were evaporated at 35 ºC (rotary evaporator Büchi 
R-210) to remove methanol. The aqueous phase was lyophilized and re-dissolved in a) 
20% aqueous methanol at 5 mg/mL and filtered through a 0.22-µm disposable LC filter 
disk for High Performance Liquid Chromatography (HPLC) analysis, or b) distilled 
water at 200 mg/mL for antifungal assays. 
 
2.4. Phenolic compounds identification and quantification 
The extracts were analysed using a Hewlett-Packard 1100 chromatograph (Agilent 
Technologies) with a quaternary pump and a diode array detector (DAD) coupled to an 
HP Chem Station (rev. A.05.04) data-processing station. A Waters Spherisorb S3 ODS-
2 C18, 3 µm (4.6 mm × 150 mm) column thermostatted at 35 °C was used. The solvents 
used were: (A) 0.1% formic acid in water, (B) acetonitrile. The elution gradient 
established was 10% B to 15% B over 5 min, 15–25% B over 5 min, 25–35% B over 10 
min, isocratic 50% B for 10 min, and re-equilibration of the column, using a flow rate of 
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0.5 mL/min. Double online detection was carried out in the DAD using 280 nm and 370 
nm as preferred wavelengths and in a mass spectrometer (MS) connected to HPLC 
system via the DAD cell outlet. 
MS detection was performed in a API 3200 Qtrap (Applied Biosystems, Darmstadt, 
Germany) equipped with an ESI source and a triple quadrupole-ion trap mass analyzer 
that was controlled by the Analyst 5.1 software. Zero grade air served as the nebulizer 
gas (30 psi) and turbo gas for solvent drying (400 ºC, 40 psi). Nitrogen served as the 
curtain (20 psi) and collision gas (medium). The quadrupols were set at unit resolution. 
The ion spray voltage was set at -4500V in the negative mode. The MS detector was 
programmed to perform a series of two consecutive modes: enhanced MS (EMS) and 
enhanced product ion (EPI) analysis. EMS was employed to record full scan spectra so 
as to obtain an overview of all of the ions in sample. Settings used were: declustering 
potential (DP) -450 V, entrance potential (EP) -6 V, collision energy (CE) -10V. 
Spectra were recorded in negative ion mode between m/z 100 and 1000. Analysis in EPI 
mode was further performed in order to obtain the fragmentation pattern of the parent 
ion(s) detected in the previous experiment using the following parameters: DP -50 V, 
EP -6 V, CE -25V, and collision energy spread (CES) 0 V. 
The phenolic compounds present in the samples were characterised according to their 
UV and mass spectra and retention times compared with commercial standards when 
available. For the quantitative analysis of phenolic compounds, a calibration curve was 
obtained by injection of known concentrations (2.5-100 µg/mL) of different standards 
compounds: catechin  (y=132.76x–59.658; R2=0.9997); caffeic acid (y=617.91x–
691.51; R2=0.9991); gallic acid (y=556.94x–738.37; R2=0.9988); isorhamnetin 
(y=629.14x–2323.4; R2=0.9967); isorhamnetin-3-O-glucoside (y=262.31x–9.8958; 
R2=1.000); kaempferol-3-O-glucoside (y=190.75x–36.158; R2=1.000); kaempferol-3-O-
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rutinoside (y=175.02x–43.877; R2=0.9999); myricetin (y=778x–1454.3; R2=0.9990); 
quercetin-3-O-glucoside (y=316.48x–2.9142; R2=1.000); and quercetin-3-O-rutinoside 
(y=222.79x–243.11; R2=0.9998); The results were expressed in µg per g of fresh weight 
(fw), as mean ± standard deviation of three independent analyses. 
 
2.5. Antifungal activity 
Four reference strains from the American Type Culture Collection (ATCC) namely 
Candida albicans (ATCC 90028), Candida tropicalis (ATCC 750), Candida glabrata 
(ATCC 2001) and Candida parapsilosis (ATCC 22019) were used in the course of this 
study. Before the experiments, all strains were grown on Sabouraud Dextrose Agar 
(SDA; Merck, Germany) for 24 h at 37 ºC. Yeast cells from at least five colonies (1 mm 
diameter) were suspended in 5 mL of sterile saline solution (0.85% NaCl). The resulting 
yeast suspension was mixed for 15 seconds with a vortex. Then, the suspension was 
adjusted by spectrophotometric method, adding saline solution to reach the value of the 
0.5 McFarland scale. The process makes final inoculums of 3.0 ± 2.0 × 106 cells/mL. 
Minimal inhibitory concentration (MIC) was determined according with the guidelines 
from the CLSI M27-A2 document (NCCLS, 2002) with some modifications. Thus, serial 
dilutions of the three plant extracts (0.05, 0.155, 0.625, 1.25, 2.5 and 5 mg/mL) were 
prepared in RPMI 1640 medium at pH 7. Aliquots of each plant extract (100 µL), at a 
twofold final concentration, were dispensed into the 96-well plates (Orange Scientific, 
Braine-l’ Alleud, Belgium). Furthermore, the plates were also incubated with aliquots 
(100 µL) at a twofold concentration of the four Candida species. Drug-free and yeast 
controls were also included. 
The 96-well plates were incubated at 37 ºC for 48h. After visualization of the resultant 
plate the MIC value was correspondent to the antifungal concentration where there was 
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no growth, by comparison with the control (cells grown without extract). Moreover, the 
number of viable cells was assessed by the determination of number of colony forming 
units (CFUs). CFUs were enumerated by plating 10 µL of each cell suspension (from 
each well) onto SDA. After 24 h of incubation at 37 ºC, the number of colonies formed 
was counted. These experiments were performed three times and, at least, in 
quadruplicate. 
 
3. Results and Discussion 
 
3.1. Identification and quantification of phenolic compounds present in the extracts 
from wild flowers 
The extraction yields for R. micrantha and C. sativa samples were similar (33.16% ± 
1.22 and 35.80% ± 1.87, respectively), being slightly higher than the one obtained for F. 
ulmaria (27.56% ± 2.01). Figure 1 shows the phenolic compounds profile of C. sativa, 
F. ulmaria and R. micrantha flowers extracts. The obtained profiles included phenolic 
acids, flavonoids including procyanidins, and hydrolysable tannins. Data (retention 
time, λmax in the visible region, molecular ion and main fragment ions observed in MS2) 
obtained by HPLC-DAD-ESI/MS analysis, identification of compounds and individual 
quantification are presented in Table 1. 
Total amounts of the different phenolics groups in the three plant samples are shown in 
Figure 2. Hydrolysable tannins were the main group in C. sativa and F. ulmaria 
samples, while flavonoids including procyanidins were the most abundant group in R. 
micrantha. Castanea sativa sample gave the highest amount of phenolic compounds 
(18973 ± 40 µg/g, fw) and hydrolysable tannins (14873 ± 110 µg/g). The highest 
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amount of phenolic acids (569 ± 20 µg/g) was determined in F. ulmaria sample, while 
the highest amount of flavonoids (6090 ± 253 µg/g) was found in R. micrantha sample. 
 
Hydroxybenzoic and hydroxycinnamic derivatives 
Gallic acid (a hydroxybenzoic acid), found in C. sativa and F. ulmaria, and 5-O-
caffeoylquinic acid (a hydroxycinnamic acid derivative), found in R. micrantha, were 
identified by comparison of their UV spectra and retention time with commercial 
standards. In the F. ulmaria sample, caffeic acid derivatives were also detected.  
 
Flavonols 
Flavonols were the only flavonoids found in the studied samples, being quercetin 
derivatives particularly abundant. Quercetin-3-O-rutinoside was found in C. sativa and 
F. ulmaria, quercetin-3-O-glucuronide and quercetin-3-O-rhamnoside were found in C. 
sativa and R. micrantha, quercetin-4´-O-glucoside was in found F. ulmaria, while 
quercetin-3-O-glucoside was found in all the analyzed samples. They showed similar 
UV spectra with λmax at 348-356 nm, and presented pseudomolecular ions [M-H]- at m/z 
609, 477, 447 and 463, respectively, all of them releasing a unique MS2 fragment at m/z 
301, corresponding to quercetin. All those compounds were positively identified 
according to their mass and UV characteristics and comparison with commercial 
standards.  
Different peaks that could be associated to quercetin pentosides according to their UV 
and mass spectral characteristics were also found in the samples. Peaks 16 in C. sativa, 
13 and 14 in F. ulmaria and 12 in R. micrantha showed a pseudomolecular ion [M-H]- 
at m/z 433, releasing a unique MS2 fragment at m/z 301, which allowed their 
identification as quercetin monopentosides. Peak 17 in F. ulmaria was also associated 
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to an unknown a quercetin pentoside derivative owing its fragment ion at m/z 433. Other 
unknown quercetin glycosides were detected in R. micrantha (peak 9, [M-H]- at m/z 
625) and C. sativa (peak 19, [M-H]- at m/z 609) and identified as a quercetin O-
hexoside-O-hexoside and a quercetin-O-rhamnoside-O-hexoside, respectively, 
according to their pseudomolecular ions and fragmentation patterns. 
Isorhamnetin derivatives were also found in all the studied samples, presenting UV 
spectra with λmax at 348-356 nm, and different pseudomolecular ions that release a 
unique MS2 fragment at m/z 315, coherent with isorhamnetin. Peaks 15 and 18 in C. 
sativa were positively identified as isorhamnetin-3-O-rutinoside and isorhamnetin-3-O-
glucoside by comparison with commercial standards, whilst the identity of the other 
peaks were established according to their pseudomolecular ions and fragmentation 
patterns and identified as isorhamnetin-O-hexoside (peak 12 in F. ulmaria, [M-H]- at 
m/z 477), isorhamnetin acetylhexoside (peak 16 in F. ulmaria, [M-H]- at m/z 519), 
isorhamnetin-O-hexoside-O-hexoside (peak 10 in R. micrantha, [M-H]- at m/z 639). 
Kaempferol derivatives were found in C. sativa and R. micrantha. Peak 14 in C. sativa 
(kaempferol-3-O-rutinoside) and peaks 16 (kaempferol-3-O-glucuronide), 17 
(kaempferol-3-O-glucoside) and 19 (kaempferol-3-O-rhamnoside) in R. micrantha were 
positively identified according to their UV and mass spectra and comparison with 
standards. Peak 20 in C. sativa (kaempferol-O-rhamnoside-O-hexoside, [M-H]- at m/z 
593) and peak 15 in R. micrantha (kaempferol-O-hexoside, [M-H]- at m/z 447) were 
assigned according to their pseudomolecular ions and fragmentation patterns. 
C. sativa was the only sample that presented myricetin derivatives, which could be 
identified as myricetin-3-O-glucuronide (peak 6), myricetin-3-O-glucoside (peak 7) and 
myricetin 3-O-pentoside (peak 12) by comparison of their UV and mass spectra with 
authentic standards. 
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Procyanidins 
Peaks 2 and 4 in C. sativa and R. micrantha samples were identified as (+)-catechin by 
comparison of UV spectrum and retention time with a commercial standard. 
Procyanidin oligomers were also detected in R. micrantha sample. Peaks 1, 2, 3, 7 and 8 
showed UV spectra with λmax 276-280 nm, characteristic of proanthocyanidins. Peaks 1, 
2 and 7 presented a pseudomolecular ions corresponding to procyanidin dimers ([M-H]- 
at m/z 577), and peaks 3 and 8 to procyanidin trimers ([M-H]- at m/z 865).  
 
Hydrolyzable tannins 
All the studied plant extracts presented compounds that showed UV spectral coherent 
with galloyl and hexahydroxydiphenol (HHDP) derivatives (Cantos et al., 2003), and in 
accordance with their mass spectra data, they were associated to different isomers of 
trigalloyl glucopyranose and di, trigalloyl-hexahydroxydiphenoyl glucopyranose (Table 
1). According to the literature, the main characteristic in the mass spectra of these 
compounds was the deprotonated molecula [M-H]- (m/z 483, 635, 787, 939, 785, 937) 
and the loss of one or more galloyl groups (152 mu) and/or gallic acid (170 mu) 
(Salminen et al., 1999; Zywicki et al., 2002). Thus, peak 3 in C. sativa with a 
pseudomolecular ion [M-H]- at m/z 635 and MS2 fragment ions at m/z 465 (loss of gallic 
acid residue), m/z 313 (loss of a galloyl residue) and m/z 169 (gallic acid) was identified 
as trigalloyl glucose. 
Peaks 4, 5, 8 and 11 in C. sativa and 7, 8 and 9 in F. ulmaria presented a 
pseudomolecular ion [M-H]-  at m/z 937 and they were identified as different isomers of 
trigalloyl-HHDP-glucopyranose. The [M-H]- ion suffered the loss of gallic acid (m/z 
797) and the fragments m/z 635, 465 were due to the loss of hexahydroxydiphenoyl 
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moieties from the [M-H]- and [M-H-gallic acid]- ions respectively. Similar ellagitannins 
have already been reported in C. sativa heartwood (Sanz et al., 2010). 
Peaks 3, 4 and 6 in F. ulmaria and 6 in R. micrantha with an m/z 785 were identified as 
isomers of digalloyl-HHDP-glucopyranose. Their fragmentation pattern involved the 
loss of galloyl and hexahydroxydiphenoyl moieties (m/z 633 and 483, respectively). The 
fragment at m/z 301 besides the [M-H-302]- ion represented an evidence of the presence 
of an HHDP group [ellagic-H]- in the molecule. 
As far as we know, there was no information on the phenolic composition of C. sativa 
and R. micrantha flowers, but a few previous studies have been published dealing with 
the phenolic composition of F. ulmaria flowers from Russia (Krasnov et al., 2006; 
Krasnov et al., 2009; Shilova et al., 2006), Poland (Fecka, 2009) and Austria (Pemp et 
al., 2007). Some differences were found in the F. ulmaria sample (flowers from 
Portugal) studied herein, including the presence of different compounds such as 
isorhamnetin glucoside derivatives and caffeic acid derivatives. Krasnov et al. (2006, 
2009) identified and isolated two quercetin glucosides (filimarin and isoquercitrin) from 
F. ulmaria aerial parts during flowering, and Fecka (2009) reported different 
ellagitannins such as rugosin A, B, D and E, which were not found in the sample herein 
studied. Pemp et al. (2007) only described flavonols in F. ulmaria sample and they did 
not identify any ellagitannin. Samples from Poland (132 ± 18 mg/g dw; Fecka, 2009) 
presented a higher concentration of phenolic compounds than the sample studied here 
(60 ± 0.8 mg/g dw; data converted in dry weight basis excluding the moisture content). 
It was not possible to compare to the quantity found in the sample from Austria, 
because the results were expressed in percentage (Pemp et al., 2007), neither with those 
of Shilvona et al. (2006) that used thin-layer chromatography for the analysis of 
phenolic compounds. 
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3.2. Antifungal activity of the extracts from wild flowers 
In the last years, the number of Candida species resistant to the common antifungal 
agents has been increasing (Bonjar, 2004). In order to overcome this problem it is of 
major importance to identify new compounds, especially natural ones, that are active 
against the most broaden spectrum of these species. In this study, the principal aim was to 
determine, for the first time, the antifungal effect of Castanea sativa, Filipendula ulmaria 
and Rosa micrantha flowers extracts against four Candida species.  
The minimum inhibitory concentration (MIC) values (Table 2) ranged from 
concentrations under 0.05 to 0.625 mg/mL. Furthermore, it is important to highlight that 
the extracts presented different activity against the different Candida species under study. 
According to the classification established by Aligiannis et al. (2001) and with the values 
present in Table 2 it is possible to assume that the extract of F. ulmaria presented a 
moderate activity against Candida albicans, but a strong effect against the other three 
species. C. sativa extract presented similar behavior, with the exception of Candida 
tropicalis, against which it also presented a moderate activity. Regarding R. micrantha 
extract, a different profile was found, since it showed a strong effect against the four 
strains assayed. This higher activity of R. micrantha extract could explain the traditional 
use of this plant to treat acne and skin conditions closely related with Candida species 
(Jain et al., 2010). Additionally, the effect of the extracts on the viability of the Candida 
species was assessed by CFU counts (Figure 3). This evaluation is of utmost importance 
to distinguish between the fungicidal and fungistatic effects. 
The results showed that all the samples presented a strong activity against the four 
Candida species studied. It should be noticed that all the extracts caused at least 2 Log of 
reduction for all strains, at the lowest concentration tested (0.05 mg/mL). Candida 
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glabrata (Figure 3) presented the highest initial inhibition for all the extracts tested, with 
more than 3 Log of reduction. However, only R. micrantha extract was able to 
completely eliminate all C. glabrata cells, in concentrations 1.25 mg/mL. These results 
confirm the fungicidal effect of this plant against C. glabrata, in detriment of the 
fungistatic effect of the other two extracts. C. sativa, F. ulmaria and R. micrantha 
extracts were able to cause a similar effect in C. parapsilosis and C. tropicalis at low 
concentrations. However, C. sativa sample was not able to cause a total inhibition of the 
former species, even in the highest concentrations tested, and R. micrantha sample was 
only able to cause a significant CFUs reduction at concentrations above than 2.5 mg/mL.  
Candida tropicalis demonstrated a strong susceptibility to all the samples, and more 
important at concentrations above 1.25 mg/mL, all the assayed extracts were able to 
cause total inhibition of the growth of this fungi species (Figure 3).  
Although being C. tropicalis often associated with urinary tract infections (Silva et al., 
2011) and F. ulmaria traditionally used on these infections, it was not observed any 
distinct effect of its extract. Interestingly, despite being C. tropicalis the NCAC species 
with the highest genetic similarity to C. albicans (Butler et al., 2009), no similarities were 
observed in terms of their sensitivity to the assayed extracts. On the contrary, C. albicans 
was the species with the lowest rate of inhibition and none of the flowers extracts tested 
was able to cause a total inhibition effect.  
 
Overall, extracts of C. sativa, F. ulmaria and R. micrantha revealed promising 
antifungal effects against Candida species. Hydrolysable tannins (e.g. tri and digalloyl 
HHDP glucose) were the main group of phenolic compounds in C. sativa and F. 
ulmaria samples, while flavonoids (e.g. (+)-catechin and procyanidin dimers and 
trimers) were the most abundant group in R. micrantha. Thus, the stronger effect 
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showed by this latter against all the Candida species and, particularly its fungicide 
effects in C. glabrata, might be related to the mentioned flavonoids that were 
inexistence in the other samples. Furthermore, the present manuscript highlights the 
importance of natural products in discovery of new antifungal compounds.  
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Table 1. Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data, relative abundances of 
fragment ions, identification and quantification of the phenolic compounds in the studied wild flowers.  
Peak 
Rt 
(min) 
λmax 
 (nm) 
Molecular ion  
[M-H]- (m/z) 
MS2 
(m/z) 
Identification 
Quantification  
(µg/g, fw) 
Castanea sativa  
1 5.0 270 169 125(100) Gallic acid 16.71 ± 0.62 
2 10.3 280 289 245(35), 203(14), 137(21) (+)-Catechin 379.94 ± 17.18 
3 13.4 276 635 465(100), 313(15), 169(6) Trigalloyl glucose 2067.68 ± 17.22 
4 13.7 276 937 937(100), 767(4), 635(4), 465(26), 301(3) Trigalloyl HHDP glucose 1508.57 ± 23.32 
5 13.9 274 937 937(100), 637(8), 465(67), 301(10) Trigalloyl HHDP glucose 9854.25 ± 73.64  
6 14.0 356 493 317(100) Myricetin 3-O-glucuronide 359.41 ± 0.09 
7 14.1 358 479 317(100) Myricetin 3-O-glucoside 380.92 ± 4.98 
8 15.3 274 937 937(100), 767(2), 637(4), 467(81), 301(25) Trigalloyl HHDP glucose 992.26 ± 65.69 
9 15.6 354 609 301(100) Quercetin 3-O-rutinoside 65.68 ± 7.90 
10 15.8 354 477 301(100) Quercetin 3-O-glucuronide 672.55 ± 51.58 
11 15.9 276 937 937(100), 767(12), 637(12), 467(20), 301(30) Trigalloyl HHDP glucose 450.54 ± 35.57 
12 16.0 356 449 317(100) Myricetin 3-O-pentoside 386.14 ± 2.94 
13 16.1 356 463 301(100) Quercetin 3-O-glucoside 899.07 ± 0.88 
14 16.8 342 593 285(100) Kaempferol 3-O-rutinoside 191.58 ± 18.99 
15 17.1 356 623 315(100) Isorhamnetin 3-O-rutinoside 135.73 ± 11.90 
16 17.3 356 433 301(100) Quercetin O-pentoside 138.75 ± 7.35 
17 17.7 348 447 301(100) Quercetin 3-O-rhamnoside 100.75 ± 7.50 
18 18.0 356 477 315(100) Isorhamnetin 3-O-glucoside 249.33 ± 6.70  
19 21.6 354 609 463(100), 301(93) Quercetin-O-rhamnoside-O-hexoside 53.05 ± 3.65 
20 23.9 356 593 447(8), 285(100) Kaempferol-O-rhamnoside-O-hexoside 71.00 ± 5.10 
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Filipendula ulmaria 
1 4.9 274 169 125(100) Gallic acid 58.97 ± 2.37 
2 8.7 330 297 179(9), 161(12), 135(100) Caffeic acid derivative 164.04 ± 11.96 
3 9.0 276 785 785(100), 633(5), 483(7), 301(38) Digalloyl-HHDP-glucose 712.87 ± 20.30 
4 11.5 276 785 785(100), 633(5), 483(17), 301(56) Digalloyl-HHDP-glucose 1462.02 ± 86.23 
5 12.2 322 297 179(36), 161(27), 135(100) Caffeic acid derivative 360.40 ± 6.19 
6 13.9 276 785 785(100), 633(4), 483(6), 301(31) Digalloyl-HHDP-glucose 529.48 ± 38.54  
7 14.4 273 937 937(100), 767 (4), 635(10), 465(7), 301(11) Trigalloyl HHDP glucose 464.39 ± 69.03 
8 14.5 276 937 937(100), 767(8), 635(4), 465(8), 301(21) Trigalloyl HHDP glucose 2091.98 ±108.72 
9 15.3 280 937 937(100), 767(6), 635(2), 465(4), 301(12) Trigalloyl HHDP glucose 1031.90 ± 26.27 
10 15.6 354 609 301(100) Quercetin-3-O- rutinoside 484.56 ±75.39 
11 16.2 354 463 301(100) Quercetin-3-O-glucoside 444.69 ± 72.78 
12 16.3 356 477 315(100) Isorhamnetin O-hexoside 542.06 ± 11.11 
13 17.1 356 433 301(100) Quercetin O-pentoside 444.85 ± 24.87  
14 17.7 354 433 301(100) Quercetin O-pentoside 376.16 ± 28.71 
15 18.5 356 463 301(100) Quercetin 4´-O-glucoside 2365.70 ± 34.64 
16 19.5 348 519 315(100) Isorhamnetin acetylhexoside 573.97 ± 17.87  
17 20.9 354 585  433(27), 301(100) Quercetin pentoside derivative 98.46± 10.48 
Rosa micrantha 
1 8.9 276 577 425(36), 289(68) Procyanidin dimer 420.18 ±36.50  
2 9.4 280 577 425(60), 289(65) Procyanidin dimer 475.74 ± 39.28  
3 9.9 280 865 865(100), 577(48), 287(17) Procyanidin trimer 289.80 ± 12.03  
4 10.2 280 289 245(55), 203(30), 137(14) (+)-Catechin  1354.14 ± 79.43 
5 10.7 326 353 191(100), 179(13), 173(2), 135(3) 5-O-caffeoylquinic acid 54.98 ± 6.99 
6 11.4 274 785 483(38), 301(100) Digalloyl-HHDP-glucose 397.10 ± 62.59 
7 12.3 280 577 425(72), 289(55) Procyanidin dimer 120.25 ± 18.71 
8 13.4 278 865 865(100), 577(27), 287(31) Procyanidin trimer 327.23 ± 44.85 
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9 14.1 354 625 463(6), 301(100) Quercetin-O-hexoside-O-hexoside 439.65 ± 15.44 
10 14.6 355 639 315(100) Isorhamnetin-O-hexoside-O-hexoside 109.97 ± 0.97 
11 15.1 346 609 447(8), 285(100) Kaempferol-O-hexoside-O-hexoside 617.66 ± 46.54  
12 15.6 356 433 301 (100) Quercetin O-pentoside 274.69 ± 22.12 
13 16.0 354 477 301 (100) Quercetin-3-O-glucuronide 291.06 ± 31.59 
14 16.3 354 463 301 (100) Quercetin-3-O-glucoside 442.39 ± 18.44 
15 17.5 347 447 285 (100) Kaempferol O-hexoside 152.60 ± 24.39 
16 17.7 348 461 285 (100) Kaempferol-3-O-glucuronide 162.49 ± 16.23 
17 17.9 346 447 285 (100) Kaempferol-3-O-glucoside  280.80 ± 24.22 
18 18.0 348 447 301 (100) Quercetin-3-O-rhamnoside 270.00 ± 17.32 
19 20.4 344 431 285 (100) Kaempferol-3-O-rhamnoside 60.98 ± 10.94 
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Table 2. Minimum inhibitory concentrations (MIC; mg/mL) of the wild flowers extracts 
against Candida species.  
 
 C. albicans	   C. glabrata	   C. parapsilosis C. tropicalis 
Castanea sativa 0.625	   < 0.05	   < 0.05 0.625 
Filipendula ulmaria 0.625	   < 0.05	   < 0.05 0.155 
Rosa micrantha 0.05	   < 0.05	   < 0.05 0.155 
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Figure 1. Individual chromatograms of the studied wild flowers: A- Castanea sativa; B- 
Filipendula ulmaria and C- Rosa micrantha all recorded at 370 nm.
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Figure 2. Total amounts of the different classes of phenolic compounds, determined by HPLC 
analysis, in the studied wild flowers.   
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Figure 3. Logarithm of number cells of C. albicans (a), C. glabrata (b), C. parapsilosis 
(c) and C. tropicalis (d) cultured in different concentrations of three plant extracts, 
formed in SDB after 48 h. Error bars represent standard deviation. 
 
 
 
